1. EP-1337 IMRT/VMAT vs. 3DCRT: the pathological and the clinical outcomes in LANSCLC treated with trimodality. (April 2019) Authors: Appel, S.; Lawrence, Y.R.; Symon, Z.; Haisraely, O.; Perlman, M.; Ofek, E.; Alezra, D.; Katzman, T.; Honig, N.; Ben-ayun, M.; Alezra, T. Rabin; Dubinsky, S.; Kraitman, J.; Tsvang, L. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1453: Urethra-sparing prostatic SBRT: extreme dosimetric optimization on rectal wall using an endorectal balloon. (April 2015) Authors: Dubouloz, A.; Tsvang, L.; Verbakel, W.; Björkqvist, M.; Linthout, N.; Linero, D.; Rouzaud, M.; Lencart, J.; Pérez-Moreno, J.M.; Ozen, Z.; Escude, L. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1343 Dose-escalated stereotactic radiotherapy for prostate cancer: A feasibility study using a rectal spacer and urethral sparing. (August 2021) Authors: Lewin, R.; Bar-Orian, I.; Honig, N.; Tsvang, L.; Ben-Ayun, M.; Weiss, I.; Symon, Z. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗